Accession Number: | 0001415889-22-004544 |
Date: | 2022-04-29 |
Issuer: | ELANCO ANIMAL HEALTH INC (ELAN) |
Original Submission Date: |
KURZIUS LAWRENCE ERIK
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD, IN 46140
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DEFERRED STOCK UNITS | 0.0 | 2022-04-29 | deemed execution date | A | 362 (a) | common stock 362 | $0.00 | 10,406 | direct |
ID | footnote |
---|---|
f1 | mr. kurzius elected to defer his director cash retainer fees pursuant to the company's directors' deferral plan (the "plan") and such deferred fees were credited to the elanco deferred stock account under the plan. each deferred stock unit is the economic equivalent of one share of elanco common stock. |
f2 | the deferred stock units will be settled in stock following the reporting person's separation of service from the company's board of directors pursuant to the plan. |
f3 | the number of deferred stock units issued is the amount of cash compensation deferred divided by the closing price of a share of elanco common stock on the grant date, which was $25.31 on april 29, 2022. |